Award

Bioavailability of Food Supplements

FOOD STANDARDS AGENCY

This public procurement record has 2 releases in its history.

Award

14 May 2026 at 10:52

Tender

06 Mar 2026 at 07:45

Summary of the contracting process

The Food Standards Agency (FSA), located in York, is overseeing a procurement process titled "Bioavailability of Food Supplements," targeting research and development consultancy services in the United Kingdom. The tender process followed an open procedure, indicating transparency and equal opportunity for all qualified suppliers. The contract was awarded on 14th May 2026, and the procurement phase is currently at the award stage, with Camrosh Limited being selected as the supplier. The contract value is set at £291,720, and the contract will run from 1st June 2026, with a completion date of 31st March 2028, alongside options for extension. The project addresses critical gaps in understanding the bioavailability and toxicological risks of novel food supplement formulations, aligning with the FSA's corporate priorities on risk analysis and consumer safety.

This project presents significant business opportunities for firms specialising in research and development consultancy, especially those with expertise in food supplements, pharmacokinetics, and toxicological assessment. Large enterprises with experience in conducting systematic literature reviews and contributing to regulatory policy development would be particularly well-suited for such engagements. The open procedure employed encourages broad participation from qualified businesses, enhancing competition and innovation in addressing a burgeoning sector need—novel formulations of food supplements. Engaging in this contract enables businesses to solidify their standing in the health and food regulatory research sectors, promoting business growth through collaboration with a key public authority like the FSA.

Find more tenders on our Open Data Platform.
How relevant is this notice?

Notice Title

Bioavailability of Food Supplements

Notice Description

The Food Standards Agency is looking to appoint 1 supplier to deliver a systematic literature review project on 'Bioavailability of Food Supplements' on a contracted basis from June 2026 until March 2028. Consumer use of food supplements has increased in recent years, accompanied by a growing trend for manufacturers to market novel formulations that claim enhanced oral bioavailability compared to conventional forms. These formulations include lipid-based systems such as liposomes, micelles, emulsions, and nanoparticles, as well as non-lipid approaches like particle size reduction through micronisation and co-formulation with polysaccharides. Although these products are often promoted as improving absorption, the supporting evidence remains limited and uncertain. This uncertainty is further increased by the vast variety of formulation types and the lack of data characterising their physicochemical properties. Consequently, the potential impact of these formulations on bioavailability and on toxicological risk, remains unclear and may pose concerns, particularly for under-characterised active ingredients and vulnerable populations. The Chemical Risk Assessment Unit (CRAU), through its risk assessments and engagement with other regulators, has identified emerging risks from food supplements intake and has sought advice from the Committee on Toxicity (COT) on several actives. The lack of information on how different formulations influence the toxicological profile of active substances remains a significant data gap in the risk assessment of food supplements. Addressing this gap is critical for ensuring robust risk assessments and informed policy decisions. In their recent report on novel formulations designed to increase food supplement bioavailability, the COT recommended that novel formulations and their active agents should be assessed for toxicokinetics on a case by case basis, using model systems that account for species differences in metabolism (COT, 2025). The COT emphasised that the feeding state (fed versus fasted) is a key determinant of bioavailability and must be critically considered when comparing across formulations. Furthermore, the suitability of acceptable daily intakes (ADIs) and other health based guidance values (HBGVs) for unformulated food supplements should always be reviewed when applied to formulations designed to increase bioavailability, and approaches for relating HBGVs to differences in bioavailability should be assessed and applied on a case by case basis (COT, 2025). The work proposed in the specification contributes to the FSA Corporate Priority EG1 - Risk Analysis informed by evidence and aligns with FSA Areas of Research Interest on novel approach methods to assess chemical hazards and impact on consumers.

Lot Information

Lot 1

Renewal: This contract will have an optional extension of 3 months from 31st March 2028

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0663a1
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/044315-2026
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
UK6 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Services
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME, VCSE
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

73 - Research and development services and related consultancy services

79 - Business services: law, marketing, consulting, recruitment, printing and security


CPV Codes

73000000 - Research and development services and related consultancy services

73110000 - Research services

73200000 - Research and development consultancy services

79310000 - Market research services

Notice Value(s)

Tender Value
£300,000 £100K-£500K
Lots Value
£300,000 £100K-£500K
Awards Value
£291,720 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
14 May 2026Today
Submission Deadline
17 Apr 2026Expired
Future Notice Date
Not specified
Award Date
13 May 2026Today
Contract Period
31 May 2026 - 31 Mar 2028 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
FOOD STANDARDS AGENCY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
YORK
Postcode
YO1 7PR
Post Town
York
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE2 North Yorkshire
Small Region (ITL 3)
TLE21 York
Delivery Location
Not specified

Local Authority
York
Electoral Ward
Guildhall
Westminster Constituency
York Central

Supplier Information

Number of Suppliers
1
Supplier Name

CAMROSH

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0663a1-2026-05-14T11:52:30+01:00",
    "date": "2026-05-14T11:52:30+01:00",
    "ocid": "ocds-h6vhtk-0663a1",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PJRM-6866-LYYX",
            "name": "Food Standards Agency",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PJRM-6866-LYYX"
            },
            "address": {
                "streetAddress": "YO1 7PR",
                "locality": "York",
                "postalCode": "YO1 7PR",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKE21"
            },
            "contactPoint": {
                "name": "FSA Commercial",
                "email": "fsa.commercial@food.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.food.gov.uk/",
                "classifications": [
                    {
                        "id": "publicAuthorityCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - central government"
                    }
                ]
            }
        },
        {
            "id": "GB-PPON-PLZJ-9375-CVRJ",
            "name": "Camrosh Limited",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PLZJ-9375-CVRJ"
            },
            "address": {
                "streetAddress": "St John's Innovation Centre, Cowley Road,",
                "locality": "Cambridge",
                "postalCode": "CB4 0WS",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKH12"
            },
            "contactPoint": {
                "email": "info@camrosh.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "vcse": false,
                "publicServiceMissionOrganization": false,
                "shelteredWorkshop": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PJRM-6866-LYYX",
        "name": "Food Standards Agency"
    },
    "tender": {
        "id": "C428403",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Bioavailability of Food Supplements",
        "description": "The Food Standards Agency is looking to appoint 1 supplier to deliver a systematic literature review project on 'Bioavailability of Food Supplements' on a contracted basis from June 2026 until March 2028. Consumer use of food supplements has increased in recent years, accompanied by a growing trend for manufacturers to market novel formulations that claim enhanced oral bioavailability compared to conventional forms. These formulations include lipid-based systems such as liposomes, micelles, emulsions, and nanoparticles, as well as non-lipid approaches like particle size reduction through micronisation and co-formulation with polysaccharides. Although these products are often promoted as improving absorption, the supporting evidence remains limited and uncertain. This uncertainty is further increased by the vast variety of formulation types and the lack of data characterising their physicochemical properties. Consequently, the potential impact of these formulations on bioavailability and on toxicological risk, remains unclear and may pose concerns, particularly for under-characterised active ingredients and vulnerable populations. The Chemical Risk Assessment Unit (CRAU), through its risk assessments and engagement with other regulators, has identified emerging risks from food supplements intake and has sought advice from the Committee on Toxicity (COT) on several actives. The lack of information on how different formulations influence the toxicological profile of active substances remains a significant data gap in the risk assessment of food supplements. Addressing this gap is critical for ensuring robust risk assessments and informed policy decisions. In their recent report on novel formulations designed to increase food supplement bioavailability, the COT recommended that novel formulations and their active agents should be assessed for toxicokinetics on a case by case basis, using model systems that account for species differences in metabolism (COT, 2025). The COT emphasised that the feeding state (fed versus fasted) is a key determinant of bioavailability and must be critically considered when comparing across formulations. Furthermore, the suitability of acceptable daily intakes (ADIs) and other health based guidance values (HBGVs) for unformulated food supplements should always be reviewed when applied to formulations designed to increase bioavailability, and approaches for relating HBGVs to differences in bioavailability should be assessed and applied on a case by case basis (COT, 2025). The work proposed in the specification contributes to the FSA Corporate Priority EG1 - Risk Analysis informed by evidence and aligns with FSA Areas of Research Interest on novel approach methods to assess chemical hazards and impact on consumers.",
        "status": "complete",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "73000000",
                        "description": "Research and development services and related consultancy services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "73200000",
                        "description": "Research and development consultancy services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "79310000",
                        "description": "Market research services"
                    },
                    {
                        "scheme": "CPV",
                        "id": "73110000",
                        "description": "Research services"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amountGross": 360000,
            "amount": 300000,
            "currency": "GBP"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "mainProcurementCategory": "services",
        "aboveThreshold": true,
        "submissionMethodDetails": "Tenders for FSA funded projects must be submitted through the health-family single e-Commercial System (Atamis), using the following link: https://health-family.force.com/s/Welcome",
        "submissionTerms": {
            "electronicSubmissionPolicy": "allowed",
            "languages": [
                "en"
            ]
        },
        "tenderPeriod": {
            "endDate": "2026-04-17T12:00:00+01:00"
        },
        "enquiryPeriod": {
            "endDate": "2026-03-20T12:00:00Z"
        },
        "awardPeriod": {
            "endDate": "2026-06-01T23:59:59+01:00"
        },
        "lots": [
            {
                "id": "1",
                "status": "complete",
                "value": {
                    "amountGross": 360000,
                    "amount": 300000,
                    "currency": "GBP"
                },
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Technical",
                            "description": "See Specification for more details. The technical criteria is broken down into 6 sections.",
                            "numbers": [
                                {
                                    "number": 80,
                                    "weight": "percentageExact"
                                }
                            ]
                        },
                        {
                            "type": "cost",
                            "name": "Commercial",
                            "description": "See specification for more details. The Commercial section is split into 5 sub-sections.",
                            "numbers": [
                                {
                                    "number": 20,
                                    "weight": "percentageExact"
                                }
                            ]
                        }
                    ]
                },
                "suitability": {
                    "sme": true,
                    "vcse": true
                },
                "contractPeriod": {
                    "startDate": "2026-06-01T00:00:00+01:00",
                    "endDate": "2028-03-31T23:59:59+01:00",
                    "maxExtentDate": "2028-06-30T23:59:59+01:00"
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "This contract will have an optional extension of 3 months from 31st March 2028"
                }
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest"
            },
            {
                "id": "020169-2026",
                "documentType": "tenderNotice",
                "noticeType": "UK4",
                "description": "Tender notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/020169-2026",
                "datePublished": "2026-03-06T07:45:53Z",
                "format": "text/html"
            }
        ],
        "contractTerms": {
            "financialTerms": "Payment of valid and undisputed invoices will be made within 30 days of receipt of the invoice or, if later, the date by which the payment falls due in accordance with the invoice, which must be submitted promptly by the Supplier. All invoices must be sent, quoting a valid Purchase Order Number (PO Number) and any other relevant details including the minimum required information set out in Section 68(9) of the Procurement Act 2023, to: fsa.payments@food.gov.uk. Within 10 Working Days of receipt of your countersigned copy of this Order Form, we will send you a unique PO Number. You must be in receipt of a valid PO Number before submitting an invoice. To avoid delay in payment it is important that the invoice is compliant and that it includes a valid PO Number, item number (if applicable) and the details (name, email, and telephone number) of your Buyer contact (i.e., Buyer Authorised Representative). Non-compliant invoices may be sent back to you, which may lead to a delay in payment."
        },
        "riskDetails": "As this is an evolving research project risks are spread across the deliverables, including but not limited to, scope, timings, regulatory changes, new scientific ways of working. Delays in obtaining, analysing, or synthesising published material could also impact delivery timelines."
    },
    "language": "en",
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "2",
                "measure": "finalStageBids",
                "value": 1,
                "relatedLot": "1"
            },
            {
                "id": "3",
                "measure": "smeFinalStageBids",
                "value": 0,
                "relatedLot": "1"
            },
            {
                "id": "4",
                "measure": "vcseFinalStageBids",
                "value": 0,
                "relatedLot": "1"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Bioavailability of Food Supplements",
            "status": "pending",
            "date": "2026-05-14T00:00:00+01:00",
            "value": {
                "amountGross": 350064,
                "amount": 291720,
                "currency": "GBP"
            },
            "mainProcurementCategory": "services",
            "aboveThreshold": true,
            "suppliers": [
                {
                    "id": "GB-PPON-PLZJ-9375-CVRJ",
                    "name": "Camrosh Limited"
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "73200000",
                            "description": "Research and development consultancy services"
                        },
                        {
                            "scheme": "CPV",
                            "id": "73000000",
                            "description": "Research and development services and related consultancy services"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "standstillPeriod": {
                "endDate": "2026-05-26T23:59:59+01:00"
            },
            "contractPeriod": {
                "startDate": "2026-06-01T00:00:00+01:00",
                "endDate": "2028-03-31T23:59:59+01:00",
                "maxExtentDate": "2028-06-30T23:59:59+01:00"
            },
            "hasRenewal": true,
            "renewal": {
                "description": "Optional extension of 3 months from 31st March 2028"
            },
            "hasOptions": true,
            "options": {
                "description": "There will be a break clause at 31st March 2027"
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "044315-2026",
                    "documentType": "awardNotice",
                    "noticeType": "UK6",
                    "description": "Contract award notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/044315-2026",
                    "datePublished": "2026-05-14T11:52:30+01:00",
                    "format": "text/html"
                }
            ],
            "assessmentSummariesDateSent": "2026-05-14T00:00:00+01:00",
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2026-05-28T23:59:59+01:00",
                    "status": "scheduled"
                }
            ]
        }
    ]
}